Exclusive: Medivation succumbs to pressure to explore sale – sources
Medivation Inc (MDVN.O) will actively seek to sell itself after the US cancer drug maker rejected a $9.3 billion takeover offer from France’s Sanofi SA (SASY.PA), according to people familiar with the situation. The San Francisco-based company has agreed to op... More »
